Healthcare -
Biotechnology - NASDAQ - US
$ 6.99
1.16 %
$ 40.3 M
Market Cap
-0.28
P/E
ATRA - CAPITAL EXPENDITURES
Capital Expenditures ATRA - Atara Biotherapeutics, Inc.
-1.22 M
LAST VALUE
66.00%
2 YEAR CAGR
49.14%
5 YEAR CAGR
-82.40%
10 YEAR CAGR